Rockwell Automation and Cytiva launch a platform to accelerate digital transformation for biopharma companies

April 29, 2026

Cytiva, a Danaher company and a leader in the life sciences industry, and Rockwell Automation, Inc. (NYSE: ROK), the world’s largest company dedicated to industrial automation and digital transformation, are jointly launching the Figurate Supervisory Control and Data Acquisition (SCADA) system designed to remove digital bottlenecks during biopharmaceutical manufacturing. Working across multiple instrument vendors and modalities, Figurate SCADA provides the connectivity needed to enable digital integration to advance modern bioprocessing.

“Biopharma teams are under pressure to move more quickly, but their systems are often not built to keep up,” says Matt Weaver, Vice President of Global Industry Life Sciences at Rockwell Automation. “This collaboration with Cytiva marks a pivotal step in our mission to democratize digital manufacturing, enabling biopharma innovators to deploy SCADA faster, smarter and more affordably.”

Many biopharma teams juggle proprietary systems that cannot communicate with one another, creating operational silos, manual workarounds, and data integrity risks. The new system directly addresses this roadblock by having an open architecture, allowing for third-party instrument integration, and real-time oversight of integration capable unit operations from a single interface.

The platform features include:

• Native interoperability: The platform is natively integrated with Cytiva bioprocessing equipment and Rockwell Automation’s FactoryTalk software suite, enabling seamless interoperability across systems.
• Scalable growth: A single platform expands from process development to commercial manufacturing without system redesign.
• Cost-effective compliance: A streamlined digital manufacturing system reduces capital and operational costs and enables cGMP compliance.
• Rapid implementation: Pre-engineered templates and modular design shorten deployment and validation timelines.
• Enhanced operational insight: Centralized alarms, real-time monitoring, process intensification and batch reporting tailored to bioprocess workflows.

Nicolas Pivet, Vice President, Manufacturing and Digital Solutions, Cytiva, says: “This collaboration is designed to empower the next generation of biomanufacturers. By combining Cytiva’s domain expertise with Rockwell’s automation leadership, we’re delivering a solution that’s both powerful and practical.”

Addressing an industry wide digital bottleneck

Industry data shows increasing demand for next generation process control systems as organizations transition toward data driven process intensification and continuous manufacturing. Equipment fragmentation remains one of the top pain points cited by biomanufacturers, particularly those advancing programs from R&D to clinical scale.

By giving teams a unified digital control layer, the Figurate SCADA reduces the risk of human error, accelerates tech transfer, and supports reliable scaleup as workloads grow in complexity.

Figurate SCADA is available globally now. Visit us to find out more.

Cytiva, the drop logo and Figurate are trademarks of Global Life Sciences Solutions USA LLC or an affiliate doing business as Cytiva.

Factory Talk is a trademark of Rockwell Automation Inc.

---

About Rockwell Automation

Rockwell Automation, Inc. (NYSE: ROK), is a global leader in industrial automation and digital transformation. We connect the imaginations of people with the potential of technology to expand what is humanly possible, making the world more productive and more sustainable. Headquartered in Milwaukee, Wisconsin, Rockwell Automation employs approximately 26,000 problem solvers dedicated to our customers in more than 100 countries as of fiscal year end 2025. To learn more about how we are bringing the Connected Enterprise® to life across industrial enterprises, visit www.rockwellautomation.com.

Media contact:

Michelle Stange
Global Public Relations, Rockwell
michelle.stange@rockwellautomation.com

About Cytiva

At Cytiva, our mission is to advance and accelerate the development of therapeutics. With 15 000 associates in more than 40 countries, we’re driven to use our expertise and talent to achieve better flexibility, capacity, and efficiency for our customers. Our broad and deep portfolio of tools and technologies, global scale, and best-in-class service provides critical support from discovery to delivery, for customers spanning researchers, emerging biotech, large-scale biopharma and contract manufacturers. Learn more at Cytiva.com

Cytiva is proud to be part of Danaher. Visit www.Danaher.com to learn more about Danaher, a leading life sciences and diagnostics innovator committed to accelerating the power of science and technology to improve human health.

Media contact:

Tania Kimball
Cytiva
tania.kimball@cytiva.com